These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nevada
|
333-171214
|
01-0949984
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
||
|
2331 Mill Road, Suite 100, Alexandria, VA
|
22314
|
|||
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
(Do not check if smaller reporting company)
|
o
|
Smaller reporting company
|
x
|
|
Page No.
|
||
|
|
||
|
Item 1.
|
Financial Statements.
|
3
|
|
Consolidated Balance Sheets
|
3
|
|
|
Consolidated Statements of Operations (unaudited)
|
4
|
|
|
Consolidated Statements of Cash Flows (unaudited)
|
5
|
|
|
Notes to Unaudited Consolidated Financial Statements.
|
6
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations.
|
27
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
36
|
|
Item 4.
|
Controls and Procedures.
|
36
|
|
|
||
|
Item 1.
|
Legal Proceedings.
|
37
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
37
|
|
Item 3.
|
Defaults upon Senior Securities.
|
37
|
|
Item 4.
|
Mine Safety Disclosures.
|
37
|
|
Item 5.
|
Other Information.
|
37
|
|
Item 6.
|
Exhibits.
|
37
|
|
MARATHON PATENT GROUP, INC. AND SUBSIDIARIES
|
||||||||
|
(FORMERLY AMERICAN STRATEGIC MINERALS CORPORATION )
|
||||||||
|
(DEVELOPMENT STAGE COMPANY)
|
||||||||
|
CONSOLIDATED BALANCE SHEETS
|
||||||||
|
September 30, 2013
|
December 31, 2012
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash
|
$ | 5,864,388 | $ | 2,354,169 | ||||
|
Accounts receivable
|
330,000 | $ | - | |||||
|
Marketable securities - available for sale securities
|
6,250 | 12,500 | ||||||
|
Prepaid expenses
|
321,025 | 40,333 | ||||||
|
Assets of discontinued operations - current portion
|
- | 82,145 | ||||||
|
Total current assets
|
6,521,663 | 2,489,147 | ||||||
|
Other assets:
|
||||||||
|
Property and equipment, net
|
8,056 | - | ||||||
|
Intangible assets, net
|
3,217,007 | 492,152 | ||||||
|
Goodwill
|
2,144,488 | - | ||||||
|
Assets of discontinued operations - long term portion
|
- | 1,035,570 | ||||||
|
Total other assets
|
5,369,551 | 1,527,722 | ||||||
|
Total Assets
|
$ | 11,891,214 | $ | 4,016,869 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 372,552 | $ | 57,158 | ||||
|
Liabilities of discontinued operations
|
30,664 | 30,664 | ||||||
|
Total liabilities
|
403,216 | 87,822 | ||||||
|
Stockholders' Equity:
|
||||||||
|
Preferred stock, $.0001 par value, 50,000,000 shares
authorized: none issued and outstanding
|
- | - | ||||||
|
Common stock, ($.0001 par value; 200,000,000 shares authorized;
5,337,679 and 3,503,565 issued and outstanding at September 30, 2013 and December 31, 2012 |
534 | 352 | ||||||
|
Additional paid-in capital
|
20,917,699 | 10,976,325 | ||||||
|
Subscription receivable
|
(25,000 | ) | - | |||||
|
Accumulated other comprehensive income - marketable securities available for sale
|
(6,250 | ) | - | |||||
|
Deficits accumulated during the development stage
|
(9,388,489 | ) | (7,037,134 | ) | ||||
|
Total Marathon Patent Group, Inc. equity
|
11,498,494 | 3,939,543 | ||||||
|
Non-controlling interest in subsidiary
|
(10,496 | ) | (10,496 | ) | ||||
|
Total stockholders' equity
|
11,487,998 | 3,929,047 | ||||||
|
Total liabilities and stockholders' equity
|
$ | 11,891,214 | $ | 4,016,869 | ||||
|
MARATHON PATENT GROUP, INC. AND SUBSIDIARIES
|
||||||||||||||||||||
|
(FORMERLY AMERICAN STRATEGIC MINERALS CORPORATION )
|
||||||||||||||||||||
|
(DEVELOPMENT STAGE COMPANY)
|
||||||||||||||||||||
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||||||
|
FOR THE THREE MONTHS
ENDED
|
FOR THE THREE MONTHS
ENDED
|
FOR THE NINE MONTHS
ENDED
|
FOR THE NINE MONTHS
ENDED
|
PERIOD FROM INCEPTION
(APRIL 30, 2011) TO
|
||||||||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||
|
Revenues
|
$ | 710,500 | $ | - | $ | 2,235,479 | $ | - | $ | 2,235,479 | ||||||||||
|
Cost of revenues
|
403,013 | - | 687,638 | - | 687,638 | |||||||||||||||
|
Gross profit
|
307,487 | - | 1,547,841 | - | 1,547,841 | |||||||||||||||
|
Expenses
|
||||||||||||||||||||
|
Amortization of patents
|
384,977 | - | 860,657 | - | 860,657 | |||||||||||||||
|
Compensation and related taxes
|
470,786 | 1,556,790 | 1,938,814 | 2,479,182 | 4,615,276 | |||||||||||||||
|
Consulting fees
|
269,012 | 92,473 | 444,921 | 1,949,067 | 2,487,065 | |||||||||||||||
|
Professional fees
|
116,373 | 79,608 | 564,597 | 449,811 | 1,079,314 | |||||||||||||||
|
General and administrative
|
108,278 | 80,255 | 315,260 | 272,793 | 632,747 | |||||||||||||||
|
Total operating expenses
|
1,349,426 | 1,809,126 | 4,124,249 | 5,150,853 | 9,675,059 | |||||||||||||||
|
Operating loss from continuing operations
|
(1,041,939 | ) | (1,809,126 | ) | (2,576,408 | ) | (5,150,853 | ) | (8,127,218 | ) | ||||||||||
|
Other income (expenses)
|
||||||||||||||||||||
|
Other income
|
- | - | - | 125,000 | 125,000 | |||||||||||||||
|
Realized loss - available for sale
|
(38,819 | ) | - | (38,819 | ) | - | (151,319 | ) | ||||||||||||
|
Interest expense
|
(243 | ) | - | (702 | ) | - | (855 | ) | ||||||||||||
|
Interest income
|
474 | 2,757 | 1,114 | 2,930 | 2,092 | |||||||||||||||
|
Total other income (expenses)
|
(38,588 | ) | 2,757 | (38,407 | ) | 127,930 | (25,082 | ) | ||||||||||||
|
Loss from continuing operations before provision for income taxes
|
(1,080,527 | ) | (1,806,369 | ) | (2,614,815 | ) | (5,022,923 | ) | (8,152,300 | ) | ||||||||||
|
Provision for income taxes
|
- | - | - | - | - | |||||||||||||||
|
Loss from continuing operations
|
(1,080,527 | ) | (1,806,369 | ) | (2,614,815 | ) | (5,022,923 | ) | (8,152,300 | ) | ||||||||||
|
Discontinued operations:
|
||||||||||||||||||||
|
Income (loss) from discontinued operations, net of tax
|
145,207 | (96,921 | ) | 263,460 | (1,426,846 | ) | (1,246,685 | ) | ||||||||||||
|
Net loss
|
(935,320 | ) | (1,903,290 | ) | (2,351,355 | ) | (6,449,769 | ) | (9,398,985 | ) | ||||||||||
|
Less: Net loss attributable to non-controlling interest
|
- | 10,395 | - | 10,496 | 10,496 | |||||||||||||||
|
Net loss attributable to Marathon Patent Group, Inc.
|
$ | (935,320 | ) | $ | (1,892,895 | ) | $ | (2,351,355 | ) | $ | (6,439,273 | ) | $ | (9,388,489 | ) | |||||
|
Loss per common share, basic and diluted:
|
||||||||||||||||||||
|
Loss from continuing operations
|
$ | (0.21 | ) | $ | (0.69 | ) | $ | (0.60 | ) | $ | (1.85 | ) | $ | (3.02 | ) | |||||
|
Loss from discontinued operations
|
0.03 | (0.04 | ) | 0.06 | (0.53 | ) | (0.46 | ) | ||||||||||||
| (0.18 | ) | (0.73 | ) | $ | (0.54 | ) | (2.38 | ) | $ | (3.48 | ) | |||||||||
|
WEIGHTED AVERAGE COMMON SHARES
OUTSTANDING - Basic and Diluted
|
5,227,840 | 2,605,776 | 4,330,208 | 2,717,610 | 2,702,318 | |||||||||||||||
|
MARATHON PATENT GROUP, INC. AND SUBSIDIARIES
|
||||||||||||
|
(FORMERLY AMERICAN STRATEGIC MINERALS CORPORATION )
|
||||||||||||
|
(DEVELOPMENT STAGE COMPANY)
|
||||||||||||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||||||
|
FOR THE NINE MONTHS
ENDED
|
FOR THE NINE MONTHS
ENDED
|
PERIOD FROM INCEPTION
(APRIL 30, 2011) TO
|
||||||||||
|
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss attributable to Marathon Patent Group, Inc.
|
$ | (2,351,355 | ) | $ | (6,439,273 | ) | $ | (9,388,489 | ) | |||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Amortization expense
|
860,657 | - | 869,430 | |||||||||
|
Amortization of prepaid expense in connection
with the issuance of common stock issued for prepaid services
|
121,564 | - | 121,564 | |||||||||
|
Depreciation expense
|
1,944 | - | 1,944 | |||||||||
|
Stock based compensation on warrants granted
|
94,930 | 2,660,800 | 2,818,092 | |||||||||
|
Stock based compensation on options granted
|
689,424 | 1,454,400 | 2,204,362 | |||||||||
|
Common stock issued for services
|
658,350 | 75,000 | 856,637 | |||||||||
|
Non-controlling interest
|
- | (10,496 | ) | (10,496 | ) | |||||||
|
Non-cash revenue
|
(1,000,000 | ) | - | (1,000,000 | ) | |||||||
|
Non-cash other income
|
- | (125,000 | ) | (125,000 | ) | |||||||
|
Realized loss - available for sale
|
38,819 | - | 151,319 | |||||||||
|
Gain on sale of assets of discontinued operations
|
(168,216 | ) | - | (168,216 | ) | |||||||
|
Impairment of mineral rights
|
- | 1,256,000 | 1,355,474 | |||||||||
|
Impairment of assets of discontinued operations
|
- | 30,248 | 30,248 | |||||||||
|
Changes in operating assets and liabilities
|
||||||||||||
|
Accounts receivable
|
(330,000 | ) | - | (330,000 | ) | |||||||
|
Assets of discontinued operations - current portion
|
82,145 | 20,000 | 20,000 | |||||||||
|
Prepaid expenses
|
39,000 | (54,516 | ) | (17,933 | ) | |||||||
|
Deposits
|
- | (235,660 | ) | (3,500 | ) | |||||||
|
Assets of discontinued operations - long term portion
|
- | 3,915 | 3,915 | |||||||||
|
Accounts payable and accrued expenses
|
315,394 | 201,193 | 372,553 | |||||||||
|
Net cash used in operating activities
|
(947,344 | ) | (1,163,389 | ) | (2,238,096 | ) | ||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Acquisition of mineral rights
|
- | (325,000 | ) | (325,000 | ) | |||||||
|
Acquisition of patents
|
(1,450,000 | ) | - | (1,950,000 | ) | |||||||
|
Note receivable - related party
|
- | (147,708 | ) | (147,708 | ) | |||||||
|
Collection on note receivable - related party
|
- | - | 147,708 | |||||||||
|
Purchase of property and equipment
|
(10,000 | ) | - | (10,000 | ) | |||||||
|
Proceeds received from the sale of marketable securities
|
129,397 | - | 129,397 | |||||||||
|
Sale of real estate property (discontinued operations)
|
1,052,320 | - | 1,628,797 | |||||||||
|
Acquisition of real estate property
|
- | (1,366,627 | ) | (1,366,627 | ) | |||||||
|
Acquisition of Cyberfone Systems, LLC (cash portion)
|
(500,000 | ) | - | (500,000 | ) | |||||||
|
Capitalized cost related to improvements of real estate property (discontinued operations)
|
(16,750 | ) | (154,620 | ) | (262,170 | ) | ||||||
|
Net cash used in investing activities
|
(795,033 | ) | (1,993,955 | ) | (2,655,603 | ) | ||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Payment on note payable
|
- | (930,000 | ) | (930,000 | ) | |||||||
|
Payment on note payable - related party
|
- | (152,974 | ) | (152,974 | ) | |||||||
|
Payment on note payable in connection with the acquisition of Cyberfone Systems, LLC
|
(500,000 | ) | - | (500,000 | ) | |||||||
|
Payment in connection with the cancellation of stock and rescission agreement
|
- | (132,000 | ) | (132,000 | ) | |||||||
|
Proceeds from disgorgement of former officer short swing profits
|
- | - | 50,000 | |||||||||
|
Proceeds from advances payables
|
- | - | 100,000 | |||||||||
|
Proceeds from promissory note - related party
|
- | - | 53,500 | |||||||||
|
Proceeds from sale of common stock, net of issuance costs
|
5,752,596 | 5,768,965 | 12,269,561 | |||||||||
|
Net cash provided by financing activities
|
5,252,596 | 4,553,991 | 10,758,087 | |||||||||
|
Net increase in cash
|
3,510,219 | 1,396,647 | 5,864,388 | |||||||||
|
Cash at beginning of period
|
2,354,169 | 129,152 | - | |||||||||
|
Cash at end of period
|
$ | 5,864,388 | $ | 1,525,799 | $ | 5,864,388 | ||||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||||||
|
Cash paid for:
|
||||||||||||
|
Interest
|
$ | 702 | $ | - | $ | 855 | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||||||
|
Issuance of a note payable to a related party in connection with
the purchase of mining rights
|
$ | - | $ | - | $ | 99,474 | ||||||
|
Issuance of common stock for advances payable
|
$ | - | $ | 100,000 | $ | 100,000 | ||||||
|
Assumption of prepaid assets upon exercise of option agreement
|
$ | - | $ | 43,157 | $ | 43,157 | ||||||
|
Assumption of accounts payable upon exercise of option agreement
|
$ | - | $ | 30,664 | $ | 30,664 | ||||||
|
Issuance of a note payable in connection with an option agreement
|
$ | - | $ | 930,000 | $ | 930,000 | ||||||
|
Issuance of common stock in connection with an option agreement
|
$ | - | $ | 1,000 | $ | 1,000 | ||||||
|
Common stock issued for acquisition of patents
|
$ | - | $ | - | $ | 925 | ||||||
|
Common stock issued in connection with the acquisition of Cyberfone Systems, LLC
|
$ | 2,280,000 | $ | - | $ | 2,280,000 | ||||||
|
Issuance of common stock issued for prepaid services
|
$ | 441,256 | $ | - | $ | 441,256 | ||||||
|
Acquisition of patents in connection with a non-cash settlement
|
$ | 1,000,000 | $ | - | $ | 1,000,000 | ||||||
|
Level 1:
|
Observable inputs such as quoted market prices in active markets for identical assets or liabilities
|
|||
|
Level 2:
|
Observable market-based inputs or unobservable inputs that are corroborated by market data
|
|||
|
Level 3:
|
Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.
|
|
Fair Value Measurements Using:
|
||||||||||||
|
|
Quoted Prices
in Active
Markets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
|||||||||
|
|
||||||||||||
|
Marketable securities – available for sale, net of discount for effect of restriction
|
$
|
-
|
$
|
-
|
$
|
6,250
|
||||||
|
For the Three Months ended
September 30, 2013
|
For the Three Months ended
September 30, 2012
|
For the Nine
Months ended
September 30, 2013
|
For the Nine Months ended September 30, 2012
|
|||||||||||||
|
Numerator:
|
||||||||||||||||
|
Loss from continuing operations
|
$ | (1,080,527 | ) | $ | (1,806,369 | ) | $ | (2,614,815 | ) | $ | (5,022,923 | ) | ||||
|
Loss from discontinued operations
|
$ | 145,207 | $ | (96,921 | ) | $ | 263,460 | $ | (1,426,846 | ) | ||||||
|
Denominator:
|
||||||||||||||||
|
Denominator for basic and diluted loss per share
|
||||||||||||||||
|
(weighted-average shares)
|
5,227,840 | 2,605,776 | 4,330,208 | 2,717,610 | ||||||||||||
|
Loss per common share, basic and diluted:
|
||||||||||||||||
|
Loss from continuing operations
|
$ | (0.21 | ) | $ | (0.69 | ) | $ | (0.60 | ) | $ | (1.85 | ) | ||||
|
Loss from discontinued operations
|
$ | 0.03 | $ | (0.04 | ) | $ | 0.06 | $ | (0.53 | ) | ||||||
|
1.
|
Significant underperformance relative to expected historical or projected future operating results;
|
|
|
2.
|
Significant changes in the manner of use of the acquired assets or the strategy for the overall business; and
|
|
|
3.
|
Significant negative industry or economic trends.
|
|
Intangible assets
|
$
|
1,135,512
|
||
|
Goodwill
|
2,144,488
|
|||
|
Net purchase price
|
$
|
3,280,000
|
|
For the nine months ended September 30, 2013
|
For the nine months ended September 30, 2012
|
|||||||
|
Pro forma revenues
|
$
|
8,135,479
|
$
|
7,609,950
|
||||
|
Pro forma income (loss) from operations
|
255,766
|
(963,396
|
)
|
|||||
|
Pro forma net income (loss)
|
480,819
|
(2,257,312
|
)
|
|||||
|
Pro forma income (loss) per share
|
$
|
0.11
|
$
|
(0.83
|
)
|
|||
|
Pro forma diluted income (loss) per share
|
$
|
0.11
|
$
|
(0.83
|
)
|
|||
|
September 30,
2013
|
December 31,
2012
|
|||||||
|
Assets:
|
||||||||
|
Prepaid expenses – current portion
|
$
|
-
|
$
|
-
|
||||
|
Deposits in real estate under contract
|
-
|
82,145
|
||||||
|
Deposit
|
-
|
-
|
||||||
|
Real estate held for sale
|
-
|
1,035,570
|
||||||
|
Assets of discontinued operations
|
$
|
-
|
$
|
1,117,715
|
||||
|
Liabilities:
|
||||||||
|
Accounts payables and accrued expenses
|
$
|
30,664
|
$
|
30,664
|
||||
|
Liabilities of discontinued operations
|
$
|
30,664
|
$
|
30,664
|
||||
|
For the Three Months ended September 30, 2013
|
For the Three Months ended September 30, 2012
|
For the Nine Months ended September 30, 2013
|
For the Nine Months ended September 30, 2012
|
|||||||||||||
|
Revenues – real estate
|
$
|
-
|
$
|
-
|
$
|
1,270,916
|
$
|
-
|
||||||||
|
Cost of sales – real estate
|
-
|
-
|
(1,064,320
|
)
|
-
|
|||||||||||
|
Gross profit
|
-
|
-
|
206,596
|
-
|
||||||||||||
|
Operating and other non-operating expenses
|
(23,009
|
)
|
(96,921
|
)
|
(111,352
|
)
|
(1,426,846
|
)
|
||||||||
|
Gain on sale of assets of discontinued operations
|
168,216
|
-
|
168,216
|
-
|
||||||||||||
|
Income (loss) from discontinued operations
|
$
|
145,207
|
$
|
(96,921
|
)
|
$
|
263,460
|
$
|
(1,426,846
|
)
|
||||||
|
September 30, 2013 (unaudited)
|
December 31, 2012
|
Weighted average
amortization period
(years)
|
|||||||||
|
Patents
|
$
|
4,086,437
|
$
|
500,925
|
3.70
|
||||||
|
Less: accumulated amortization
|
(869,430)
|
(8,773)
|
|||||||||
|
$
|
3,217,007
|
$
|
492,152
|
||||||||
|
2013
|
$
|
345,327
|
||
|
2014
|
991,734
|
|||
|
2015
|
756,690
|
|||
|
2016
|
484,978
|
|||
|
2017 and thereafter
|
638,278
|
|||
|
Total
|
$
|
3,217,007
|
|
|
Number of Warrants
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Life (Years)
|
|||||||||
|
Balance at December 31, 2012
|
199,162 | $ | 7.02 | 6.52 | ||||||||
|
Granted
|
582,175 | 6.50 | 3.00 | |||||||||
|
Cancelled
|
- | - | - | |||||||||
|
Forfeited
|
(73,077 | ) | 6.50 | 8.92 | ||||||||
|
Exercised
|
- | - | - | |||||||||
|
Balance at September 30, 2013
|
708,260 | $ | 6.65 | 4.40 | ||||||||
|
Warrants exercisable at September 30, 2013
|
680,055 | $ | 6.67 | |||||||||
|
Weighted average fair value of warrants granted during the period ended
|
$ | 6.50 | ||||||||||
|
Number of Options
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Life (Years)
|
||||||||||
|
Balance at December 31, 2012
|
153,846
|
6.50
|
9.87
|
|||||||||
|
Granted
|
794,230
|
5.05
|
4.03
|
|||||||||
|
Exercised
|
-
|
-
|
-
|
|||||||||
|
Forfeited
|
-
|
-
|
-
|
|||||||||
|
Cancelled
|
(105,769)
|
11.05
|
4.70
|
|||||||||
|
Balance outstanding at September 30, 2013
|
842,307
|
$
|
4.91
|
5.46
|
||||||||
|
Options exercisable at September 30, 2013
|
102,564
|
$
|
6.56
|
|||||||||
|
Options expected to vest
|
739,743
|
|||||||||||
|
Weighted average fair value of options granted during the period
|
$
|
3.54
|
||||||||||
|
Cost
|
Gross
Unrealized
Gains/(losses) (Comprehensive Income)
|
Gross
Realized
Gains/(losses) (Statement of Operations)
|
Fair
Value
|
|||||||||||||
|
Publicly traded equity securities – available for sale
|
$
|
12,500
|
(6,250)
|
(38,819
|
)
|
$
|
6,250
|
|||||||||
|
|
Level 1:
|
Observable inputs such as quoted market prices in active markets for identical assets or liabilities
|
|
Level 2:
|
Observable market-based inputs or unobservable inputs that are corroborated by market data
|
|
|
Level 3:
|
Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.
|
|
For the Three Months ended
September 30, 2013
|
For the Three Months ended
September 30, 2012
|
For the Nine
Months ended
September 30, 2013
|
For the Nine Months ended September 30, 2012
|
|||||||||||||
|
Amortization of patents
|
$
|
384,977
|
$
|
-
|
$
|
860,657
|
$
|
-
|
||||||||
|
Professional fees
|
116,373
|
79,608
|
564,597
|
449,811
|
||||||||||||
|
Compensation and related taxes
|
470,786
|
1,556,790
|
1,938,814
|
2,479,182
|
||||||||||||
|
Consulting fees
|
269,012
|
92,473
|
444,921
|
1,949,067
|
||||||||||||
|
Travel and related expenses
|
22,180
|
12,613
|
77,096
|
93,404
|
||||||||||||
|
Other general and administrative
|
86,098
|
67,642
|
238,164
|
179,389
|
||||||||||||
|
Total
|
$
|
1,349,426
|
$
|
1,809,126
|
$
|
4,124,249
|
$
|
5,150,853
|
||||||||
|
·
|
Amortization of patents: Amortization expenses were $860,657 and $0 during the nine months ended September 30, 2013 and 2012, respectively, an increase of $860,657 or 100%. Amortization expenses were $384,977 and $0 during the three months ended September 30, 2013 and 2012, respectively, an increase of $384,977 or 100%. We have no comparable expense from the 2012 prior periods as we have acquired the patents beginning in November 2012.
|
|
|
|
·
|
Professional fees: For the nine months ended September 30, 2013 and 2012, professional fees were $564,597 and $449,811, respectively, an increase of $114,786 or 26%. For the three months ended September 30, 2013 and 2012, professional fees were $116,373 and $79,608, respectively, an increase of $36,765 or 46%. Professional fees include fees incurred for audits and legal fees related to public company filing requirements. The increase is primarily due to an increase in accounting and legal fees related to public company filing and reporting requirements. Additionally, during the three and nine months ended September 30, 2013 professional fees included stock based legal fees of $65,370 and $66,328, respectively.
|
|
|
·
|
Compensation expense and related taxes: Compensation expense includes salaries and stock-based compensation to our employees. For the nine months ended September 30, 2013 and 2012, compensation expense and related payroll taxes were $1,938,814 and $2,479,182, respectively, a decrease of $540,368 or 22%. For the three months ended September 30, 2013 and 2012, compensation expense and related payroll taxes were $470,786 and $1,556,790, respectively, a decrease of $1,086,004 or 70%. The decrease is primarily attributable to a decrease in stock based compensation of approximately $1,300,000 and $1,100,000 for the three and nine months ended September 30, 2013, respectively, in connection with warrant and option granted to our directors and officers and offset by an increase in salaries due to the hiring of our executive and management employees and support staff in 2013. During the nine months ended September 30, 2013 and 2012, we recognized stock based compensation of $1,203,678 and $2,335,790, respectively. During the three months ended September 30, 2013 and 2012, we recognized stock based compensation of $245,310 and $1,504,290, respectively.
|
|
|
·
|
Consulting fees: For the nine months ended September 30, 2013 and 2012, we incurred consulting fees of $444,921, and $1,949,067, respectively, a decrease of $1,504,146 or 77%, which is primarily attributable to a decrease in stock based consulting expense of approximately $1.5 million in connection with warrant granted to consultants for consulting
on strategic acquisitions and advice on capital restructuring
during the nine months ended September 30, 2012. For the three months ended September 30, 2013 and 2012, we incurred consulting fees of $269,012 and $92,473, respectively, an increase of $176,539 or 191%, which is primarily attributable to an increase in hiring of consultants for investor relations and business advisory services in 2013. During the nine months ended September 30, 2013 and 2012, we recognized stock based consulting of $294,262 and $1,779,410, respectively. During the three months ended September 30, 2013 and 2012, we recognized stock based consulting of $200,067 and $42,472, respectively.
|
|
·
|
Travel and related expenses: Travel expenses were $77,096 and $93,404 during the nine months ended September 30, 2013 and 2012, respectively, a decrease of $16,308 or 17%. This decrease during the nine month period is due to a decrease in business development related travel. Travel expenses were $22,180 and $12,613 during the three months ended September 30, 2013 and 2012, respectively, an increase of $9,567 or 76%.
|
|
|
·
|
Other general and administrative expenses: For the nine months ended September 30, 2013 and 2012, other general and administrative expenses were $238,164 and $179,389, respectively, an increase of $58,775 or 33%. For the three months ended September 30, 2013 and 2012, other general and administrative expenses were $86,098 and $67,642, respectively, an increase of $18,456 or 27%. Other general and administrative expenses include postage, general insurance, office supplies, utilities, rent expense and office expenses. Such increase is primarily attributable to an increase in operations.
|
|
For the Three Months ended September 30, 2013
|
For the Three Months ended September 30, 2012
|
For the Nine Months ended September 30, 2013
|
For the Nine Months ended September 30, 2012
|
|||||||||||||
|
Revenues – real estate
|
$
|
-
|
$
|
-
|
$
|
1,270,916
|
$
|
-
|
||||||||
|
Cost of sales – real estate
|
-
|
-
|
(1,064,320
|
)
|
-
|
|||||||||||
|
Gross profit
|
-
|
-
|
206,596
|
-
|
||||||||||||
|
Operating and other non-operating expenses
|
(23,009
|
)
|
(96,921
|
)
|
(111,352
|
)
|
(1,426,846
|
)
|
||||||||
|
Gain on sale of assets of discontinued operations
|
168,216
|
-
|
168,216
|
-
|
||||||||||||
|
Income (loss) from discontinued operations
|
$
|
145,207
|
$
|
(96,921
|
)
|
$
|
263,460
|
$
|
(1,426,846
|
)
|
||||||
|
31.1
|
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
|
|
31.2
|
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
|
|
32.1
|
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
|
|
32.2
|
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
|
|
101.ins
|
XBRL Instance Document
|
|
101.sch
|
XBRL Taxonomy Schema Document
|
|
101.cal
|
XBRL Taxonomy Calculation Document
|
|
101.def
|
XBRL Taxonomy Linkbase Document
|
|
101.lab
|
XBRL Taxonomy Label Linkbase Document
|
|
101.pre
|
XBRL Taxonomy Presentation Linkbase Document
|
|
MARATHON PATENT GROUP, INC.
|
|
|
By:
|
/s/ Doug Croxall
|
|
Name: Doug Croxall
|
|
|
Title: Chief Executive Officer and Chairman
|
|
|
(Principal Executive Officer)
|
|
|
By:
|
/s/ John Stetson
|
|
Name: John Stetson
|
|
|
Title: Chief Financial Officer, Secretary and Director
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|